Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptide
LBP
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN979219
Aperçu rapide pour Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptide (ABIN979219)
Antigène
LBP
(Lipopolysaccharide Binding Protein (LBP))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LBP antibody (Catalog #: ARP41545_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LBP (Lipopolysaccharide Binding Protein (LBP))
-
Sujet
-
LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI
Alias Symbols: MGC22233, BPIFD2
Protein Interaction Partner: APOA1,CAMP,CD14,CFHR1,RPS21,APOA1,CD14,CFHR1,IRF6
Protein Size: 481 -
Poids moléculaire
- 51 kDa
-
ID gène
- 3929
-
NCBI Accession
- NM_004139, NP_004130
-
UniProt
- P18428
Antigène
-
Vous êtes ici:
